MedPath

Comparison of satisfaction and adherence among once-daily, twice-daily, and once-weekly DPP-4 inhibitors in type 2 diabetic patients

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000018170
Lead Sponsor
Shiraiwa Medical Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

- Patients with severe hepatic, renal, and/or cardiac disease - Patients with hypersentitivity to the agents used in the current study - Patients who are pregnant, breast-feeding or may become pregnant - Patients who are judged by the investigator to be inappropriate for this study for any other reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients' satisfaction
Secondary Outcome Measures
NameTimeMethod
Adherence Blood glucose
© Copyright 2025. All Rights Reserved by MedPath